Literature DB >> 7508490

Virus-induced autoimmunity in hepatitis C virus infections: a rare event.

B M McFarlane1, C Bridger, C J Tibbs, M G Saleh, A Fuzio, G Verucchi, L Attard, A Boschi, F Chiodo, I G McFarlane.   

Abstract

Serial serum samples from 16 Italian patients presenting with acute hepatitis C virus (HCV) infections (which progressed to chronic hepatitis in six) were screened for the non-organ-specific autoantibodies most frequently associated with autoimmune hepatitis (AIH), as well as for antibodies against the hepatic asialoglycoprotein receptor (ASGP-R) and against the GOR peptide. One patient had low titres (1:10-1:80) of liver-kidney microsomal (LKM-1) antibodies during the recovery phase and three others had transient low titres of anti-smooth muscle (IgM class, 1:10) or anti-ASGP-R (1:150-1:300). Anti-GOR was detected in 43 (65%) of 66 sera from 13 of these patients. There was no correlation between any of these findings and progression to chronicity. By comparison, 18 patients with AIH studied concurrently before institution of immunosuppressive therapy all had antinuclear and/or smooth muscle antibodies, or LKM-1, at 1:40-1:640 and anti-ASGP-R at 1:300-1:2,100. None of these 18 had evidence of HCV infection and all were seronegative for anti-GOR. The findings indicate that the autoantibodies usually associated with AIH are rare in HCV infections but the virus can very occasionally induce a transient autoimmune response. Anti-GOR appears to be an antibody specifically related to HCV infection and is probably not a marker of induced autoimmunity, and it does not predict progression to chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508490     DOI: 10.1002/jmv.1890420113

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I.

Authors:  Xue-Ping Wang; Leslie Goodwin; Pamela Kahn; Craig Gawel; Cheston B Cunha; Benjamin Laser; Benjamin Sahn; Mark H Kaplan
Journal:  J Biomol Tech       Date:  2006-07

2.  The GOR gene product cannot cross-react with hepatitis C virus in humans.

Authors:  R Koike; T Iizuka; T Watanabe; N Miyasaka
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 3.  Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination.

Authors:  Albert J Czaja
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

4.  Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection.

Authors:  Y-Y Wu; T-C Hsu; T-Y Chen; T-C Liu; G-Y Liu; Y-J Lee; G J Tsay
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

5.  Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.

Authors:  G V Gregorio; P Pensati; R Iorio; A Vegnente; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

6.  Understanding the presence of false-positive antibodies in acute hepatitis.

Authors:  Sasan Sakiani; Christopher Koh; Theo Heller
Journal:  J Infect Dis       Date:  2014-06-18       Impact factor: 5.226

7.  Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies.

Authors:  Juan A Quiroga; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

8.  Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B.

Authors:  Tomasz I Michalak
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

9.  Direct-Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis.

Authors:  Camila C Simoes; Omar A Saldarriaga; Netanya S Utay; Ashley E Stueck; Sheharyar K Merwat; Shehzad N Merwat; Thomas D Schiano; Maria Isabel Fiel; Heather L Stevenson
Journal:  Hepatol Commun       Date:  2019-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.